Sernova and Seraxis Merge to Create BetaNova Biotherapeutics
TORONTO, Canada and GERMANTOWN, Maryland — September 8, 2026 Sernova Biotherapeutics Inc. and Seraxis Holdings, Inc. announced a definitive...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
TORONTO, Canada and GERMANTOWN, Maryland — September 8, 2026 Sernova Biotherapeutics Inc. and Seraxis Holdings, Inc. announced a definitive...
Las Vegas, Nevada, USA, September 7, 2026 The community-acquired bacterial pneumonia (CABP) treatment market is expected to expand through...
Silver Spring, Maryland, USA, September 5, 2026 The U.S. Food and Drug Administration (FDA) has announced steps intended to...
Boston, Massachusetts, USA, September 1, 2026 Vertex Pharmaceuticals Incorporated has completed its acquisition of Crinetics Pharmaceuticals, Inc., strengthening its...
Amsterdam, the Netherlands – August 27, 2026 argenx announced the successful completion of its acquisition of Forte Biosciences, Inc.,...
San Diego, California / Alderley Park, United Kingdom — August 14, 2026 Skye Bioscience, Inc. and Redx Pharma Limited...
REDWOOD CITY, Calif., Aug. 14, 2026 asper Therapeutics, Inc. reported continued progress in its immune-mediated disease portfolio following the...
Thousand Oaks, California & Salt Lake City, Utah, August, 10, 2026 Teledyne Technologies Incorporated and Varex Imaging Corporation have...
Bridgewater, N.J., August 10, 2026 Grifols announced the completion of patient follow-up in SPARTA, its Phase 3 outcomes study...
Bridgewater, N.J., August 10, 2026 Amneal Pharmaceuticals, Inc. has completed its acquisition of Kashiv BioSciences, LLC, creating a scaled,...
